Rubix LS's mission is to connect and power the world's healthcare data with diverse patient analytics. We aim to tackle disease diagnosis disparities and therapeutic outcomes for underrepresented patients from rare and ultra rare disease, infectious disease and oncology disease disciplines. As the nature of life science research leans more toward patient-centricity and health equity, here at Rubix LS, we're evolving the way that clinical research can be deployed to incorporate clinical research in any location, anywhere, no matter where the participant community may reside.  As a community-based contract research organization and research and development firm, we've taken patient data analytics further.  Taking the current state of underserved and underrepresented participant journeys, we're translating that data to design bespoke clinical trial designs that match the participant community capabilities to streamline Ph I - Ph II trials that provide access to the communities that needed therapeutic innovations yesterday.